Home/Pipeline/Eteplirsen

Eteplirsen

Duchenne Muscular Dystrophy

CommercialMarketed

Key Facts

Indication
Duchenne Muscular Dystrophy
Phase
Commercial
Status
Marketed
Company

About CSL

CSL Limited is one of the world's largest biotechnology companies, specializing in plasma-derived therapies, vaccines, and innovative medicines. With a global presence spanning over 35 countries and employing more than 27,000 people, CSL has built a reputation for scientific excellence and operational expertise over more than a century. The company's diversified portfolio includes life-saving treatments for rare diseases, critical care medicines, and seasonal and pandemic vaccines.

View full company profile

Other Duchenne Muscular Dystrophy Drugs

DrugCompanyPhase
Undisclosed DMD Program(s)WaVe Life SciencesPreclinical